Patent details

Basic Information

Publication number:

EP2544673

PCT Application Number:

US2011027606

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117092734

PCT Publication Number:

WO2011112623

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

THIOXANTHONE-BASED AUTOPHAGY INHIBITOR THERAPIES TO TREAT CANCER

French Title of Invention:

THÉRAPIES UTILISANT UN INHIBITEUR D'AUTOPHAGIE À BASE DE THIOXANTHONE POUR TRAITER LE CANCER

German Title of Invention:

AUF THIOXANTHON BASIERENDER AUTOPHAGIEHEMMTHERAPIEN ZUR BEHANDLUNG VON KREBS

SPC Number:

Dates

Filing date:

08/03/2011

Grant date:

20/02/2019

EP Publication Date:

16/01/2013

PCT Publication Date:

15/09/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/02/2019

EP B1 Publication Date:

20/02/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/03/2019

Expiration date:

08/03/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/02/2019

 

 

Name:

Spectrum Pharmaceuticals, Inc.

Address:

157 Technology Drive, Irvine, CA 92618, United States (US)

Inventor

1

Name:

CAREW, Jennifer, S,

Address:

United States (US)

2

Name:

REDDY, Guru

Address:

United States (US)

3

Name:

NAWROCKI, Steffan, T.

Address:

United States (US)

Priority

Priority Number:

311736 P

Priority Date:

08/03/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/167; A61K 31/18; A61K 31/382; A61P 35/00; A61P 35/02;

Publication

European Patent Bulletin

Issue number:

201908

Publication date:

20/02/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages